Localization of nitric oxide synthase in saphenous vein grafts havested with a novel "no-touch" technique: Potential role of nitric oxide contribution to improved early graft patency rates

Journal of Vascular Surgery

Volumn 35, Issue 2, 2002, Pages 356-362

  Tsui, Janice C S ^a   Souza, Domingos S R ^b   Filbey, Derek ^b   Karlsson, Mats G ^b   Dashwood, Michael R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Orebo Medical Centre Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ADVENTITIA; ANALYSIS OF VARIANCE; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; GRAFT PATENCY; HISTOCHEMISTRY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; AGED; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GRAFT OCCLUSION; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SAPHENOUS VEIN; SWEDEN; TRANSPLANTATION; VASCULAR ENDOTHELIUM; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NADPH DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SAPHENOUS VEIN; SWEDEN; VASCULAR PATENCY;

EID: 0036482335     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.121072     Document Type: Article

References (40)

1. Mehta D, Izzat MB, Bryan AJ, Angelini GD. Towards the prevention of vein graft failure. Int J Cardiol 1997;62(Suppl 1):S55-63.
2. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989;79:I24-9.
3. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994;9:641-9.
4. Soyombo AA, Angelini GD, Bryan AJ, Newby AC. Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein. Cardiovasc Res 1993;27:1961-7.
5. Souza D. A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg 1996;30:41-4.
6. Souza DS, Bomfim V, Skoglund H, Dashwood MR, Borowice JW, Bodin L, et al. High early patency of saphenous vein graft for coronary artery bypass harvested with surrounding tissue. Ann Thorac Surg 2001;71:797-800.
7. Souza DS, Christofterson RH, Bomfim V, Filbey D. 'No-touch' technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass grafting maintains an intact endothelium. Scand Cardiovasc J 1999;33:323-9.
8. Tsui I, Souza DS, Filbey D, Bomfim V, Dashwood MR. Preserved endothelial integrity and nitric oxide synthase in human saphenous vein harvested by a novel 'no-touch' technique. Br J Surg 2001; 88:1209-15.
9. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
10. Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide syntheses in the cardiovascular system. Cardiovasc Res 1999;43:509-20.
11. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 1991;88:7797-801.
12. Gundry SR, Jones M, Ishihara T, Ferrans VJ. Optimal preparation techniques for human saphenous vein grafts. Surgery 1980;88: 785-94.
13. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68.
14. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg 1997; 63:582-91.
15. Barker SG, Talbert A, Cottam S, Baskerville PA, Martin JF. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb 1993;13:70-7.
16. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996;94:1655-64.
17. Schwartz SM, deBlois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-65.
18. Sellke FW, Boyle EM Jr, Verrier ED. Endothelial cell injury in cardiovascular surgery: the pathophysiology of vasomotor dysfunction. Ann Thorac Surg 1996;62:1222-8.
19. Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease. Arch Pathol Lab Med 1989;113:772-6.
20. Cines DR, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
21. Shi Q, Wu HD, Sauvage LR, Durante KR, Patel M, Wechezak AR, et al. Re-endothelialization of isolated segments of the canine carotid artery with reference to the possible role of the adventitial vasa vasorum. J Vasc Surg 1990;12:476-85.
22. Zurbrugg HR, Wied M, Angelini GD, Hetzer R. Reduction of intimal and medial thickening in sheathed vein grafts. Ann Thorac Surg 1999;68:79-83.
23. Izzat MB, Mehta D, Bryan AJ, Kewby AC, Angelini GD. The influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation 1996; 94:1741-5.
24. Angelini GD, Christie MI, Bryan AJ, Lewis MJ. Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg 1989;48:417-20.
25. Roubos N, Rosenfeldt FL, Richards SM, Conyers RA, Davis BB. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation 1995;92: II31-6.
26. Cracowski JL, Stanke-Labesque F, Sessa C, Hunt M, Chavanon U, Devillier P, et al. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein. Can J Physiol Pharmacol 1999;77:770-6.
27. O'Neil GS, Chester AH, Schyns CJ, Tadjkarimi S, Borland JA, Yacoub MH. Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. J Thorac Cardiovasc Surg 1994;107:699-706.
28. Costello KB, Stewart DJ, Baffour R. Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery. Eur J Pharmacol 1990;186:311-4.
29. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, et al. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells. Microvasc Res 2000;60:269-80.
30. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999;19:1156-61.
31. Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, et al. Vein adaptation to arterialization in an experimental model. J Vasc Surg 2001;33:561-9.
32. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A 2001; 98:4202-8.
33. Gurjar MV, Sharma RV, Bhalla RC. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 1999;19:2871-7.
34. Papadaki M, Tilton RG, Eskin SG, McIntire LV. Nitric oxide production by cultured human aortic smooth muscle cells: stimulation by fluid flow. Am J Physiol 1998;274:H616-26.
35. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 1998;83:1271-8.
36. Binko J, Meachem S, Majewski H. Endothelium removal induces iNOS in rat aorta in organ culture, leading to tissue damage. Am J Physiol 1999;276:E125-34.
37. Comini L, Bachetti T, Gaia G, Pasini E, Agnoletti L, Pepi P, et al. Aorta and skeletal muscle NO synthase expression in experimental heart failure. J Mol Cell Cardiol 1996;28:2241-8.
38. Gonzalez C, Barroso C, Martin C, Gulbenkian S, Estrada C. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J Cereb Blood Flow Metab 1997;17: 977-84.
39. Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S, et al. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol 2000;20:E96-100.
40. Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, et al. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol 2001;21:201-7.